All patient identifiers were removed prior to analysis, with medical record numbers replaced by unique study identifiers
Table of Contents Why GLP-1 Medications May Cause Increased Urination Common Urinary Side Effects of GLP-1 Receptor Agonists When Frequent Urination on GLP-1 Treatment Needs Medical Attention Managing Increased Urination While Taking GLP-1 Medications Other Factors That May Affect Urination During GLP-1 Therapy Scientific References Frequently Asked Questions Why GLP-1 Medications May Cause Increased Urination GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss
Retatrutide targets three incretin-adjacent receptors
Improve skin appearance: Are you dealing with premature skin aging, sun damage, or scarring
Users have reported significant improvements in skin texture and overall appearance after consistent use
GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
.png)
